Arno Therapeutics, Inc., a clinical stage biopharmaceutical company, is developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information, visit the company’s website at www.arnothera.com.